Neural tube defects are a group of birth defects that occur when the embryonic structure destined to become the brain and spinal cord fails to close properly during the first few weeks of pregnancy. They affect roughly 1 in every 1,000 pregnancies worldwide, and range from conditions compatible with a full lifespan to those that are invariably fatal. Folic acid supplementation and flour fortification have cut rates dramatically in many countries, yet tens of thousands of affected pregnancies still occur each year, driven by genetics, metabolism, medication use, and uneven public-health policy.
What Actually Happens in the Embryo
The neural tube is the embryonic precursor to the entire central nervous system. It forms during the third and fourth weeks after conception, when a flat sheet of cells along the embryo’s back folds upward and fuses along the midline, like a zipper closing from multiple points. The process depends on precisely coordinated cell movements, signaling pathways, and mechanical forces acting in concert.
When closure fails at the head end, the result is anencephaly, the absence of most of the brain and skull. Failure at the lower end produces spina bifida, in which part of the spinal cord and its coverings protrude through an opening in the vertebrae. A third, rarer type, encephalocele, involves brain tissue pushing through a gap in the skull, usually at the back of the head. These defects are established before most people even realize they are pregnant, which is why prevention strategies focus on nutrient status before and around the time of conception.
The Main Types and What They Mean
Anencephaly is the most severe form. It involves the total or partial absence of the calvarium and brain, with a mortality rate of 100 percent either before birth or within hours to days afterward.1PubMed Central. The etiopathogenic and morphological spectrum of anencephaly: a comprehensive review of literature There is no surgical treatment, and pregnancies diagnosed with anencephaly are managed with supportive counseling.
Spina bifida is far more variable. The mildest form, spina bifida occulta, is a small gap in the spine that often produces no symptoms at all and may never be discovered. The more serious open form, myelomeningocele, exposes spinal cord tissue and membranes to the outside, causing nerve damage that affects movement, bladder and bowel control, and sometimes cognition. Open spina bifida also triggers a cascade of secondary brain abnormalities. Research using conditional gene deletion in mice has confirmed that the Chiari II brain malformation, which affects roughly 90 percent of children with open spina bifida, arises as a direct consequence of the spinal defect rather than as a separate genetic problem.2PubMed Central. Chiari II brain malformation is secondary to open spina bifida That hindbrain herniation frequently leads to hydrocephalus, which often requires a shunt to drain excess cerebrospinal fluid.
Encephalocele is the least common of the three. It presents as a sac-like protrusion of brain tissue through the skull, most often at the back of the head, though frontal encephaloceles occur in some populations. Outcomes depend heavily on how much brain tissue is involved and whether it can be surgically repaired.
Why Folic Acid Matters So Much
The link between folic acid and neural tube defects is one of the clearest success stories in preventive medicine. Folate, the natural form of vitamin B9, is essential for DNA synthesis and for the chemical reactions that regulate gene expression. When folate is scarce during the critical window of neural tube closure, genes involved in that closure process get dialed down. In laboratory studies, folate deficiency triggers a specific chain of epigenetic changes: it increases a particular type of protein tagging on chromosomes, which in turn suppresses genes needed for the neural tube to close normally.3PubMed Central. Folate deficiency induced H2A ubiquitination to lead to downregulated expression of genes involved in neural tube defects Restoring folic acid reversed those changes in the same experiments.
Beyond that direct gene-silencing pathway, folate deficiency also disrupts methylation, the process cells use to chemically mark DNA and proteins. Without enough folate, the supply of methyl groups drops, leading to widespread irregularities in how genes are turned on and off during early development.4PubMed Central. Abnormal methylation caused by folic acid deficiency in neural tube defects These epigenetic disruptions may explain why folate’s protective effect extends beyond simple DNA replication and touches the regulation of the entire developmental program.5PubMed Central. The emerging role of epigenetic mechanisms in the etiology of neural tube defects
Flour Fortification and Its Global Impact
Countries that have made folic acid fortification of flour mandatory have seen dramatic drops in neural tube defect rates. A meta-analysis of mandatory fortification programs found an overall 44 percent reduction in risk, with North American countries seeing a 54 percent drop and South American countries a 39 percent reduction.6PubMed Central. The effectiveness of mandatory folic acid fortification compared with pre-fortification periods on reducing neural tube defects (NTDs): a systematic review and meta-analysis Canada’s experience is a useful example: after mandatory fortification began, the prevalence of neural tube defects fell from about 1.58 per 1,000 births to 0.86 per 1,000, a 46 percent reduction. The decline was proportional to how high rates were beforehand, and geographic differences across provinces largely disappeared.7PubMed. Reduction in neural-tube defects after folic acid fortification in Canada
Costa Rica saw roughly a 60 percent reduction, and Chile saw rates fall from about 19 per 10,000 births to 7 per 10,000 within a decade of fortification.8PubMed Central. Impact of folic acid fortification of flour on neural tube defects: a systematic review Brazil also documented significant decreases in the center, southeast, and south of the country following its mandate.9PubMed Central. Prevention of neural tube defects by the fortification of flour with folic acid: a population-based retrospective study in Brazil
The gap between mandatory and voluntary fortification is striking. Populations with mandatory programs have an average prevalence of about 4.2 neural tube defects per 10,000 births, compared to 7.6 per 10,000 in countries with only voluntary fortification and 9.7 per 10,000 in countries with no fortification at all. In other words, mandatory fortification is associated with about half the rate of neural tube defects, while voluntary programs only achieve about a 20 percent reduction.10PubMed Central. Global heterogeneity in folic acid fortification policies and implications for prevention of neural tube defects and stroke: a systematic review Many countries in Europe, Asia, and Africa still lack mandatory programs, which means that tens of thousands of preventable cases continue to occur every year simply because of policy gaps.
Genetic Risk Factors
Folic acid does not prevent all neural tube defects, partly because genetics play a significant role. The most studied gene in this context is MTHFR, which encodes an enzyme that processes folate in the body. A common variant of this gene, known as the C677T mutation, produces a less stable version of the enzyme. People who inherit two copies of this variant have a modestly higher risk of having an affected pregnancy. A large meta-analysis of published literature found that the C677T variant was associated with about a 23 percent increase in neural tube defect risk.11PLOS ONE. Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature A second MTHFR variant, A1298C, has been reported as a risk factor in some family-based studies, though the meta-analytic evidence for it is less consistent.12PubMed Central. Methylenetetrahydrofolate reductase mutations, a genetic cause for familial recurrent neural tube defects
Beyond MTHFR, the same meta-analysis found suggestive evidence for a variant in the RFC-1 gene, which encodes the main transporter that moves folate into cells, with a roughly 55 percent increase in risk.13PLOS ONE. Genetic Variants in the Folate Pathway and the Risk of Neural Tube Defects: A Meta-Analysis of the Published Literature But no single gene variant explains more than a fraction of cases. Neural tube closure involves hundreds of genes working in concert, governing cell signaling, tissue mechanics, and gene regulation simultaneously.14PubMed Central. Neural tube closure: cellular, molecular and biomechanical mechanisms The picture that has emerged is one of complex, multifactorial risk, where many small genetic contributions interact with environmental exposures.
Other Risk Factors Beyond Genetics
Maternal obesity is one of the strongest non-genetic risk factors. A systematic review and meta-analysis found that obese women had about 62 percent higher odds of a pregnancy affected by a neural tube defect compared to women of normal weight. Being merely overweight, however, did not carry a statistically significant increase.15PubMed. Risk of neural tube defects according to maternal body mass index: a systematic review and meta-analysis The mechanism likely involves the metabolic disturbances associated with obesity. A study examining features of metabolic syndrome found that having even one feature, such as elevated blood sugar or abnormal cholesterol, roughly doubled the odds of an affected pregnancy, while having two or more features raised the odds more than sixfold.16PubMed Central. Metabolic syndrome features and risk of neural tube defects
Certain medications are well-established risk factors. Valproic acid, widely prescribed for epilepsy and bipolar disorder, is one of the most significant. Laboratory research has shown that valproic acid causes DNA damage in embryonic tissue, triggers cell death in the developing head region, and generates reactive oxygen species that disrupt normal cellular processes.17PubMed. Valproic acid-induced DNA damage increases embryonic p27(KIP1) and caspase-3 expression: a mechanism for valproic-acid induced neural tube defects 18Molecular Pharmacology. Valproic Acid Increases Conservative Homologous Recombination Frequency and Reactive Oxygen Species Formation: A Potential Mechanism for Valproic Acid-Induced Neural Tube Defects Women of childbearing age on valproic acid are generally counseled to use effective contraception and, if planning pregnancy, to discuss alternative medications with their doctor.
Environmental toxins also contribute. Fumonisins, a group of mold-produced chemicals found in contaminated corn, have been linked to higher rates of neural tube defects in populations that rely heavily on maize-based diets. Along the Texas-Mexico border, women who consumed moderate to high amounts of tortillas during the first trimester had roughly two and a half times the odds of an affected pregnancy compared to low consumers, after adjusting for other risk factors.19PubMed Central. Exposure to fumonisins and the occurrence of neural tube defects along the Texas-Mexico border Animal studies have confirmed the same pattern: administering purified fumonisin to pregnant mice increases neural tube defects in their offspring.20PubMed. Maternal fumonisin exposure as a risk factor for neural tube defects The mechanism appears to involve disruption of folate metabolism and sphingolipid pathways critical for cell membrane integrity.
Prenatal Screening and Diagnosis
Neural tube defects can be detected during pregnancy through blood tests and ultrasound. The traditional screening method measures alpha-fetoprotein in the mother’s blood during the second trimester. This protein leaks from the exposed fetal tissue into the amniotic fluid and then into maternal circulation. For anencephaly, blood screening catches roughly 95 percent of cases, but for open spinal defects its sensitivity drops to about 65 to 80 percent.21Obstetrics & Gynecology Science. Prenatal screening for neural tube defects: from maternal serum alpha-fetoprotein to ultrasonography
Routine ultrasound has increasingly become the frontline screening tool, and evidence suggests it outperforms blood testing alone. In one large study, 25 percent of confirmed neural tube defect cases had normal blood test results and would have been missed without ultrasound. Most diagnoses were initially picked up by routine second-trimester ultrasound without any prior blood-test alert.22Obstetrics & Gynecology. Routine Ultrasonography Compared With Maternal Serum Alpha-fetoprotein for Neural Tube Defect Screening In practice, most programs now use a combination of both approaches, with ultrasound serving as the primary detection method in settings where it is readily available.
Fetal Surgery for Spina Bifida
One of the most striking advances in managing spina bifida has been the development of fetal surgery, in which the open spinal defect is repaired while the baby is still in the womb. The landmark MOMS trial compared prenatal repair before 26 weeks of gestation with the standard approach of repairing the defect after birth. The results were dramatic: only 40 percent of babies who had prenatal surgery needed a shunt for hydrocephalus, compared to 82 percent in the postnatal surgery group. Prenatal repair also improved motor function and reduced hindbrain herniation by 12 months of age.23PubMed Central. A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele
The trade-off is real, though. Prenatal surgery carries a higher risk of preterm birth and complications related to the uterine incision.24PubMed Central. Fetal surgery for spina bifida: past, present, future A systematic review of outcomes in the decade following the MOMS trial found that hydrocephalus and Chiari malformations remained more common in babies treated after birth, while overall mortality was actually slightly higher in the prenatally treated group, likely reflecting the risks of operating on very premature infants.25PubMed Central. Myelomeningocele Surgery over the 10 Years Following the MOMS Trial: A Systematic Review of Outcomes in Prenatal versus Postnatal Surgical Repair The decision involves weighing the neurological benefits against the obstetric risks, and it is typically made in specialized fetal surgery centers after extensive counseling.
Living with Spina Bifida as an Adult
Thanks to modern surgical and medical care, most people born with spina bifida today survive into adulthood. But the long-term picture is complex. A cohort study following adults with spina bifida found that about 42 percent had normal IQ scores, and those who never needed a brain shunt tended to score higher. About 44 percent attended regular education, and 8 percent earned college degrees. Thirty percent lived independently, and about 54 percent drove a car.26PubMed Central. Consequences of Spina Bifida: A Cohort Study
Mobility varied with the level of nerve involvement. People with the highest spinal lesions all used wheelchairs, while those with lower-level defects could walk, sometimes part-time. Over half experienced pressure sores, and four people in the cohort required major limb amputations as a result. Unemployment was high, at 56 percent, and only about 23 percent had been married.
As people with spina bifida age, certain challenges tend to worsen. Bowel and urinary incontinence rates increase over time, while the ability to walk independently tends to decline. Both bowel and urinary incontinence are independent predictors of lower quality of life in adults, with bowel incontinence having a negative impact regardless of its severity.27PubMed. Multidisciplinary management of people with spina bifida across the lifespan Lifelong, coordinated care involving urology, orthopedics, neurosurgery, and rehabilitation specialists is the current standard, though access varies enormously by country and healthcare system.
Inositol and Folate-Resistant Cases
Folic acid prevents a large share of neural tube defects, but not all. Researchers have been searching for supplementary approaches that could help in cases where folic acid alone is not enough. The most promising candidate so far is inositol, a naturally occurring sugar-like molecule involved in cell signaling. In curly tail mice, a strain genetically predisposed to spina bifida that does not respond to folic acid, inositol supplementation significantly reduced the incidence of spinal defects.28PubMed. Inositol prevents folate-resistant neural tube defects in the mouse The protective effect appears to work through a completely different pathway than folic acid, stimulating cell signaling cascades that promote proper closure of the lower end of the neural tube.
More recent work suggests that inositol’s benefit may be mediated through enhanced supply of nucleotides during the critical window of neural tube closure.29PubMed. Association of embryonic inositol status with susceptibility to neural tube defects, metabolite profile, and maternal inositol intake A small pilot trial in humans tested inositol alongside folic acid in women who had previously had an affected pregnancy. None of the pregnancies in the inositol group developed a neural tube defect, while one case of anencephaly occurred in the folic acid-only group.30PubMed Central. Inositol for the prevention of neural tube defects: a pilot randomised controlled trial The numbers were too small to draw firm conclusions, but the results were encouraging enough to warrant larger trials. If inositol proves effective in humans, a combined supplement could potentially reach cases that folic acid alone misses.
Regenerative Approaches on the Horizon
Standard fetal surgery for spina bifida provides mechanical closure of the defect but does not regenerate damaged nerve tissue. Researchers are now exploring whether stem cells and bioengineered materials could move beyond repair toward actual restoration of spinal cord function. Preclinical studies in rodent and sheep models have tested mesenchymal stem cells derived from amniotic fluid and placenta, combined with scaffold materials, as patches for the open defect. These cells appear to exert protective effects through chemical signaling rather than by directly replacing neurons, promoting blood vessel growth and damping inflammation.31PubMed Central. Advances in Fetal Repair of Spina Bifida Integrating Prenatal Surgery, Stem Cells, and Biomaterials
In one rat model, bone marrow stem cells seeded onto a scaffold and transplanted into fetuses with spina bifida survived, grew, and expressed markers of neural cells. The spinal defect shrank visibly, and skin closure improved in many of the treated animals.32PubMed Central. Application potential of bone marrow mesenchymal stem cell (BMSCs) based tissue-engineering for spinal cord defect repair in rat fetuses with spina bifida aperta These results are still a long way from human application, but they represent a conceptual shift from covering the defect to trying to heal the underlying nerve damage. If the approach translates, it could meaningfully change the functional outcomes for children born with myelomeningocele.
Ethical Dimensions of Prenatal Diagnosis
Detecting a neural tube defect during pregnancy places families in extraordinarily difficult territory. The diagnosis arrives early enough that termination is a legal option in many jurisdictions, but the spectrum of outcomes, especially for spina bifida, is wide enough that predicting any individual child’s future is nearly impossible. A baby born with a low-level spinal lesion may walk independently and attend mainstream school; one with a high-level lesion may face lifelong wheelchair use, multiple surgeries, and chronic health challenges.
When fetal anomalies are diagnosed, families need clear, balanced information about the realistic range of outcomes, the option of fetal surgery where appropriate, and what life with the condition actually looks like. Research on counseling practices has emphasized that parental autonomy and informed consent should be central, including the right to refuse testing entirely or to choose not to learn certain genetic results.33PubMed. Fetal anomaly diagnosis and termination of pregnancy The quality of counseling matters: studies have pointed out that historical justifications for screening sometimes framed disability primarily as a cost to society rather than centering the well-being of the family.34PubMed Central. Ethics, justification and the prevention of spina bifida Advocacy organizations and adults living with spina bifida have pushed for prenatal counseling that reflects the actual experiences of people with the condition, not just the medical complications listed in a textbook.